Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 24;15:2921–2933. doi: 10.2147/IJN.S247443

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Wang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

In vivo antitumor evaluation. (A) MDA-MB-231 tumor growth curves, (B) body weight with various treatments, (C) survival curve, and (D) tumor growth inhibition rates (n = 5). *P < 0.05 and **P < 0.01. (E) Tumor tissue images under various treatments. Scale bars are 100 μm. (F) Tumor tissue Western blotting results of p53 expression under various treatments: *P < 0.05, **P < 0.01, and ***P < 0.001.

Abbreviations: PTX, paclitaxel; 2DA-ICG-PTX, 2-glucosamine-fluorescein-5(6)-isothiocyanate-glutamic acid-paclitaxel; 2DA-ICG-PTX NPs, 2-glucosamine-fluorescein-5(6)-isothiocyanate-glutamic acid-paclitaxel nanoparticles.